The global chin augmentation market size is expected to reach USD 2.01 billion by 2030, registering at a CAGR of 6.8% from 2023 to 2030, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the changing aesthetic needs, recognition of dermal fillers for chin augmentation by regulatory bodies, and growing collaboration between manufacturers and other service intermediaries. Moreover, the growing aging population globally propels the demand for chin augmentation as various aesthetic surgeries focused on the face and head are preferred by the adult population who portray signs of aging. According to the American Society of Plastic Surgeons report in 2020, hyaluronic acid-based fillers were used predominantly in those aged between 40 to 54 years.
The availability to finance cosmetic surgeries at distributed monthly cost propels patients to undergo cosmetic procedures such as chin augmentation in developed countries such as the U.S. and Germany. Furthermore, leading manufacturers of dermal fillers are actively collaborating with service providers to increase their product-target penetration. For instance, in April 2022, PatientFi and Allergan Aesthetics expanded their marketing agreement, allowing the former company to provide financing options to the latter’s product portfolio. The agreement will propel the usage of Juvederm fillers such as Volluma and Volux for chin augmentation procedures.
In addition, growing product approvals for dermal fillers for chin augmentation applications propels the market growth. For instance, in June 2020, AbbVie received U.S. FDA approval for Juvederm Volluma to augment the chin. Similarly, in February 2021, Galderma received regulatory approval for Restylane Defyne to correct moderate to mild chin retrusion in adults aged 21 and over.
Request a free sample copy or view report summary: Chin Augmentation Market Report
The global market was estimated at USD 1.20 billion in 2022 and is expected to reach USD 2.01 billion in 2030
The global market is expected to grow at a compound annual growth rate of 6.8% from 2023 to 2030
In 2022, North America dominated the market in terms of a revenue share of 34.95%. This growth can be attributed to the increasing acceptability of cosmetic procedures, growing product approvals from federal regulatory bodies, and a rising number of service providers
The surgical segment dominated the revenue share in 2022 and accounted for 69.62% in 2022 of the market
Cosmetic surgery centers dominated the market with a revenue share of 54.92% in 2022, due to the availability of advanced infrastructure, shorter waiting time, and the ability to serve patients on an outpatient preference
Grand View Research has segmented the global chin augmentation market based on procedure, gender, end-use, and region:
Chin Augmentation Procedure Outlook (Revenue, USD Billion, 2018 - 2030)
Surgical
Chin Implant
Bone Advancement
Non-Surgical
Chin Augmentation Gender Outlook (Revenue, USD Billion, 2018 - 2030)
Female
Male
Chin Augmentation End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Cosmetic Surgery Centers
Hospitals
MedSpas
Chin Augmentation Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Chin Augmentation Market
New York Plastic Surgical Group
Westlake Dermatology & Cosmetic Surgery
Nazarian Plastic Surgery
Ruby Surgery & Aesthetics
Cadogan Clinics
UK Aesthetic
UK Healthcare Aesthetics Center
Marroquin & Sandoval Plastic Surgery
Advanced Cosmetic Surgery.
Orange County Facial Plastic Surgery.
"The quality of research they have done for us has been excellent..."